A Pilot Study of Acalabrutinib With Bendamustine/Rituximab Followed by Cytarabine/Rituximab for Untreated Mantle Cell Lymphoma

被引：0
|
作者：
不详
机构：
来源：
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY | 2021年 / 19卷 / 04期
关键词：
TRIAL;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：12 / 12
页数：1
相关论文
共 50 条
  • [21] Successful retreatment with 3-week rituximab-bendamustine with high-dose dexamethasone in patients with relapsed/refractory mantle cell lymphoma
    Lamm, Wolfgang
    Kiesewetter, Barbara
    Puhr, Hannah
    Dolak, Werner
    Mayerhoefer, Marius E.
    Raderer, Markus
    ANNALS OF HEMATOLOGY, 2019, 98 (06) : 1519 - 1520
  • [22] Effect of bendamustine in combination with rituximab on QT interval duration in patients with advanced de novo indolent non-Hodgkin or mantle cell lymphoma
    Burke, John M.
    van der Jagt, Richard H. C.
    Flinn, Ian W.
    Craig, Michael D.
    Chen, Ling
    Morganroth, Joel
    Munteanu, Mihaela C.
    MacDonald, David A.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (01) : 211 - 216
  • [23] Results of a phase I-II study of fenretinide and rituximab for patients with indolent B-cell lymphoma and mantle cell lymphoma
    Cowan, Andrew J.
    Stevenson, Phillip A.
    Gooley, Ted A.
    Frayo, Shani L.
    Oliveira, George R.
    Smith, Stephen D.
    Green, Damian J.
    Roden, Jennifer E.
    Pagel, John M.
    Wood, Brent L.
    Press, Oliver W.
    Gopal, Ajay K.
    BRITISH JOURNAL OF HAEMATOLOGY, 2017, 176 (04) : 583 - 590
  • [24] Outcomes of patients with indolent lymphoma treated with bendamustine plus rituximab compared to rituximab plus CVP or CHOP chemoimmunotherapy in Ontario
    Suleman, Adam
    Aktar, Suriya J. J.
    Ante, Zharmaine
    Liu, Ning
    Chan, Kelvin K. W.
    Cheung, Matthew C. C.
    Prica, Anca
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 202 (06) : 1104 - 1118
  • [25] Bendamustine plus rituximab for relapsed or refractory diffuse large B cell lymphoma: a multicenter retrospective analysis
    Hong, Jung Yong
    Yoon, Dok Hyun
    Suh, Cheolwon
    Kim, Won Seog
    Kim, Seok Jin
    Jo, Jae-Cheol
    Kim, Jin Seok
    Lee, Won-Sik
    Oh, Sung Yong
    Park, Yong
    Kim, Sung-Yong
    Lee, Mark Hong
    Lee, Ho Sup
    Do, Young Rok
    ANNALS OF HEMATOLOGY, 2018, 97 (08) : 1437 - 1443
  • [26] Rituximab maintenance after bendamustine-based treatment for follicular lymphoma and mantle cell lymphoma may exert a negative influence on SARS-CoV-2 infection outcomes
    Serna, Angel
    Navarro, Victor
    Iacoboni, Gloria
    Lopez, Laia
    Sancho, Juan-Manuel
    Gonzalez-Barca, Eva
    Lopez-Garcia, Alberto
    Cordoba, Raul
    Saez, Adolfo
    Jimenez-Ubieto, Ana
    Ferrero, Ainara
    Garcia, Tomas
    Sanchez, Angela
    Garcia, Cristina
    Bosch, Marc
    Cabirta, Alba
    Jimenez, Moraima
    Marin-Niebla, Ana
    Bosch, Francesc
    Abrisqueta, Pau
    HAEMATOLOGICA, 2025, 110 (01) : 173 - 178
  • [27] Modified VR-CAP, Alternating With Rituximab and High-dose Cytarabine: An Effective Pre-transplant Induction Regimen for Mantle Cell Lymphoma
    Smith, Stephen D.
    Gandhy, Shruti
    Gopal, Ajay K.
    Reddy, Prathima
    Shadman, Mazyar
    Till, Brian G.
    Lynch, Ryan C.
    Kanan, Sandra
    Cowan, Andrew
    Low, Lauren
    Hill, Brian T.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (01) : 48 - 52
  • [28] Role of Rituximab and Rituximab Biosimilars in Diffuse Large B-Cell Lymphoma
    Coleman, Morton
    Lammers, Philip E.
    Ciceri, Fabio
    Jacobs, Ira A.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2016, 16 (04) : 175 - 181
  • [29] Fludarabine, cyclophosphamide, and rituximab chemotherapy followed by rituximab maintenance in follicular lymphoma: high efficacy may come at a cost?
    Tam, Constantine S.
    Seymour, John F.
    LEUKEMIA & LYMPHOMA, 2011, 52 (05) : 729 - 731
  • [30] Premature closure of a phase II study of bendamustine, mitoxantrone and rituximab for patients with untreated high-risk follicular lymphoma due to severe haematological and infectious toxicity
    Cheah, Chan Y.
    Nastoupil, Loretta J.
    McLaughlin, Peter
    Fanale, Michelle A.
    Neelapu, Sattva S.
    Fayad, Luis E.
    Hagemeister, Frederick B.
    Fowler, Nathan H.
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 175 (03) : 531 - 533
12345